Summary: Environmental enrichment is known to positively influence the organism's psychologic and physiologic well-being. However, the effects of environmental enrichment on immune responses and cancer prognosis have not been clearly established and its impact on cancer therapy is unknown. Here, we report that environmental enrichment mediated a statistically significant improvement of the outcome of immunotherapy in an experimental model of B-cell lymphoma. When mice were immunized with an idiotype-vaccine, those maintained under enriched environmental conditions produced statistically significant higher levels of anti-idiotype antibodies and revealed more attenuated tumor growth than those housed in standard environments. Most strikingly, enriched tumor-bearing mice had statistically significant prolonged survival, with 44% of them disease-free compared with 0% in the standard rearing tumor-bearing mice. The possible mechanisms for the enhancement of immunotherapy by environmental enrichment are cognitive, physical activity, and psychologic. The demonstration of synergistic effect of cancer therapy and environmental enrichment on tumor rejection has important implication for cancer treatment.
T he importance of environmental enrichment in brain function and plasticity has long been recognized in neuroscience. The standard definition of an enriched environment is ''a combination of complex inanimate and social stimulation.'' 1 In mice, the enriched environment consists of social interactions and stimulation of exploratory and motor behavior with objects, such as toys, ladders, tunnels, and a running wheel for voluntary physical exercise, items that are routinely changed during the experimental period. In addition, the enriched environment consists of larger cages made of wire mesh. The wire mesh enables the mice to climb all over the cage, whereas the larger cage area compensates for the area that is occupied by the enrichment equipment and provides more space. 2 The effect of environmental enrichment on immunity has not been thoroughly investigated and is a controversial topic. Although some studies demonstrated an effect of enriched environment on immune responses, other studies could not detect such an effect. [3] [4] [5] We previously showed that enriched environment increased natural killer (NK) cell activity in mice. 6 This finding has major implications for cancer because of the important role of NK cells in tumor immunity. NK cells, a subpopulation of leukocytes involved in innate immunity, are known to recognize and kill a variety of tumor and virally infected cells. [7] [8] [9] In recent years, a variety of immunotherapy approaches have been extensively studied in preclinical and clinical trials for cancer treatment. Immunoglobulin idiotypes (Ids) of malignant B cells are tumor-specific antigens that serve as targets for immunotherapy. Studies in laboratory animals demonstrated that immunization against idiotypic determinants of B-cell tumors induced tumor resistance. 10, 11 As a result, Id-vaccination has been initiated in clinical trials to control residual disease in B-cell lymphoma and multiple myeloma. 12, 13 In the present report, we used the experimental model of the murine 38C-13 B-cell lymphoma 10, 11 to determine whether exposure to an enriched environment could enhance the therapeutic effect of vaccination.
MATERIALS AND METHODS

Animals and Rearing Conditions
One-month-old C3H/eB male mice were obtained from the animal facility of the Tel Aviv University, Israel. All procedures with animals were carried out in Throughout the experiment, the animals were maintained on a 12-hour on: 12-hour off lighting schedule (lights on at 06.00 h) in a room thermostatically maintained at 22 ± 11C. Ad libitum food and water were available. The mice were housed in 2 differential environmental conditions throughout whole experiments. Fifty percent of the mice were reared in an enriched environment ( Fig. 1) , which consisted of 5 mice per cage in large wire mesh cages (47 Â 30 Â 22.5 cm) containing a variety of stimuli, that is, ladders, tunnels, and a running wheel, that were replaced weekly, as previously described. 1 The remaining mice were housed in standard plastic cages (31 Â 22 Â 15 cm) without any exposure to stimulation (control mice). The housing conditions for control mice conformed European Economic Community directive 86/ 609 for animal housing. Accordingly, the control mice did not show any signs of crowding; they did not lose weight, or did they bite each other or showed any signs of aggression, which are all accepted parameters for crowding. The bedding in all cages was sawdust.
Cell Lines
38C-13 is a carcinogen-induced B-cell tumor that expresses IgM on the cell surface.
14 Cells were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 50 mM 2-mercaptoethanol.
Immunization and Tumor Challenge
D2 hybridoma has been obtained upon somatic cell hybridization between 38C-13 and an immunoglobulinnegative myeloma cell line, as previously described. 15 This ''rescue'' hybridoma secretes large amounts of IgM with an idiotypic specificity identical to that of 38C-13. D2 hybridoma cells were grown as ascites. 38C-13 IgM protein was purified from ascites by ammonium sulfate precipitation and size fractionation, as described.
16 38C-13 IgM protein was coupled to Keyhole limpet hemocyanin (KLH) using 0.1% glutaraldehyde as described 17 to form idiotype-KLH (Id-KLH). Six-week-old mice were injected with Id-KLH (25 mg/mouse) emulsified in complete Freund's adjuvant, and boosted 2 weeks later with the same conjugate in incomplete Freund's adjuvant. Two weeks after the second immunization, mice were challenged subcutaneously with 1 Â 10 5 38C-13 tumor cells and followed-up for tumor growth and survival. Tumor size was measured by calipers 3 times a week. Tumor area was calculated by multiplying horizontal diameter by vertical diameter. The tumor measurements were not performed in a blinded fashion. For determination of survival, mice were allowed to die from the disease (as was approved by the animals' committee in 2001). Nevertheless, mice that were in distress were killed.
Enzyme-linked Immunosorbent Assay (ELISA)
Levels of anti-Id antibodies in sera of immunized mice were determined by ELISA. Each mouse serum was analyzed individually in duplicate. Immunoglobulin Id proteins at a concentration of 2 mg/mL were adsorbed to 96-well ELISA plates for 18 hours at 41C. Plates were then washed, blocked with 1% bovine serum albumin for 1 hour at 371C and rewashed. Serial dilutions of sera were then added to plates for 2-hour incubation at room temperature. Plates were washed, and horseradish-peroxidase-conjugated rabbit antimouse IgG (Jackson Immuno Research, West Grove, PA) was added for 1-hour incubation at room temperature. Plates were washed and developed for 15 minutes with 1,2-orthophenylenediamine. Mouse serum, containing a known amount of anti-Id antibodies (0.1 mg/mL), was used as a standard. Standards and blanks were included in the same plate as the experimental samples. Absorbance at 450 nm was measured by an ELISA reader.
Statistical Analysis
All results were calculated as mean ± SEM values, and were analyzed using Statistical Package for the Social Sciences (SPSS) 11 software (SPSS, Chicago, IL). Differences between groups were analyzed by analysis of variance with repeated measures. Statistical analyses on survival curves were performed using log rank. Levels of significance are indicated, with significance accepted at the P<0.05 level.
RESULTS
Environmental Enrichment Prolongs Survival of Untreated Tumor-bearing Mice
One-month-old mice were randomly divided into 2 groups and maintained under standard rearing or enriched rearing conditions throughout the experiment. At the age of 10 weeks, all mice were inoculated subcutaneously with 1 Â 10 5 38C-13 lymphoma cells and monitored for tumor growth and survival. The results revealed prolonged survival of the environmentally enriched mice, compared with mice in the standard environment, that almost reached significance ( Fig. 2A) , with no significant difference in the size of the primary subcutaneous tumor between the 2 groups (data not shown). These results indicate that environmental enrichment has some beneficial effect on tumor endurance.
Beneficial Effect of Enriched Environment on the Outcome of Immunotherapy
One-month-old mice were randomly assigned to 2 groups and matured under standard rearing or enriched rearing conditions throughout the experiment. At the age of 6 weeks, all mice were immunized with the 38C-13 IgM, conjugated to KLH and emulsified in complete Freund's adjuvant, followed 2 weeks later with the same conjugate in incomplete Freund's adjuvant. Two weeks after the second immunization, 5 mice in each group were bled, and levels of anti-Id antibodies in their sera were determined by ELISA. The remaining mice were challenged with 1 Â 10 5 38C-13 tumor cells subcutaneously, and followed-up for tumor growth and survival. Figure  3A shows that vaccination of standard-rearing mice suppressed tumor growth, as revealed by the significant decrease in tumor size (P<0.001). However, vaccinated mice maintained under enriched conditions had significantly smaller tumors (P<0.05) than vaccinated mice maintained under standard housing conditions (Fig. 3B) . There was no difference in tumor growth between untreated mice and adjuvant-treated mice (data not shown). Vaccination alone modestly improved the survival of the standard-rearing mice. In contrast, survival of vaccinated mice was markedly enhanced (P<0.001) by environmental enrichment (Fig. 2B) . It should be emphasized that environmentally enriched mice that survived until day 100 were free of tumor. There was no difference in survival between untreated mice and adjuvant-treated mice (data not shown).
Environmentally Enriched Mice Show Higher Levels of Anti-Id Antibodies
Sera collected 2 weeks after the second immunization were tested for anti-Id antibodies by ELISA. Mouse serum containing a known amount of anti-Id antibodies (0.1 mg/mL) was used as a standard in all antibody titrations. As depicted in Figure 4 , environmentally enriched mice showed significantly higher levels of antiId antibodies than mice maintained under the standard rearing conditions (P<0.001).
DISCUSSION
In this work we have shown that environmental enrichment has a beneficial effect on tumor endurance. The results revealed prolonged survival of the environmentally enriched mice, compared with mice in the standard environment. Moreover, a synergistic effect between vaccination and enriched environment resulted in 44% disease-free long-term survival in mice maintained in the enriched environment compared with 0% in mice maintained in the standard environment. It is noteworthy that we intentionally inoculated 1 Â 10 5 tumor cells, a very high dose for the highly tumorigenic 38C-13 tumor, which is therefore minimally affected by vaccination. 10 The finding that environmental enrichment increased FIGURE 2. A, Environmental enrichment (EE) prolongs survival of untreated tumor-bearing mice. Ten-week-old mice were inoculated subcutaneously with 1 Â 10 5 38C-13 tumor cells after spending 6 weeks in an enriched environment or in standard housing conditions. Survival was recorded daily (n = 28 in each group). This graph presents 3 different experiments). B, Environmental enrichment (EE) prolongs survival of immunized tumor-bearing mice. Six-week-old mice, maintained under enriched rearing or standard rearing conditions, were immunized twice with Id-KLH, or untreated. Mice were challenged with 1 Â 10 5 38C-13 cells 2 weeks after the second immunization. Survival was recorded daily. Significance level is *P<0.05 (log rank; n = 20 in each group) between immunized and nonimmunized standardrearing mice, and ***P<0.001 (log rank; n = 20 in each group) between enriched immunized mice and standardrearing immunized mice. This graph presents 2 different experiments. There are possible immune mechanisms underlying the impact of enrichment on immunotherapy. Environmentally enriched mice manifested in this work an increased immunologic reactivity in response to Id-vaccination. In addition, we have previously demonstrated that environmental enrichment enhances NK cell activity. 6 These 2 immune components enhanced in enriched mice may contribute to their tumor resistance. It is well established that antibodies play a predominant role in the destruction of B-cell lymphoma in Idvaccinated mice. 18, 19 A variety of mechanisms may play an important role in the therapeutic action of antibodies on tumor cells including induction of apoptosis, complement-mediated lysis, and antibody-dependent cellmediated cytotoxicity (ADCC). It has been reported that immunostimulatory agents, such as CpG-A oligodeoxynucleotides, enhance the efficacy of monoclonal antibody therapy of lymphoma by enhancing ADCC, largely by activating NK cells. 20 In general, ADCC seems to be one of the most important effector mechanisms of antibody action against cancer cells. 21 We therefore suggest that the enhanced therapeutic effect of Idvaccination in an enriched environment resulted from the combination of increased anti-Id antibody production and enhanced NK cell activity. Thus, environmental enrichment may also improve the outcome of monoclonal antibody therapy (such as Rituxan for non-Hodgkin lymphoma), which involves ADCC as an effector mechanism. In addition, Id-specific T cells, both CD4 + and CD8 + , may have also contributed to the antitumor effects in Id-vaccinated mice. Immunization with lipidconjugated Id, as used in the present study, elicits preferentially anti-Id antibodies that play the major role in destruction of lymphoma cells. 18, 19 Induction of significant T-cell responses requires application of Id vaccines combined with granulocyte/macrophage colony-stimulating factor, 22 or Id-loaded dendritic cell vaccines. 23 However, it is possible that environmentally enriched mice responded to the lipid conjugated vaccine with increased levels of Id-specific T cells that were high enough to play a role in destruction of lymphoma cells. Nevertheless, previous studies could not show higher levels of basal T lymphocytes in enriched animals. 24, 25 Enrichment can enhance the immune system via 3 main routes (cognitive, physical activity, and psychologic):
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First, it is known for some decades that enriched environment increases the thickness of the cortex, including frontal, parietal, and occipital cortices. It is also known for increasing the size of synaptic contacts, number of dendritic spines, and dendritic branching. 26, 27 Many studies demonstrated that immunoregulatory processes are influenced by the brain. 28 The highest cognitive region of the brain, the neocortex, has a role in immune regulation. For example, lesion studies of the cerebral cortex resulted in enhancing or inhibiting effects on the immune system. Specifically, NK cells reactivity is controlled by the left brain cortex. [29] [30] [31] Moreover, it has been shown that mental stimulation, thought to stimulate the dorsolateral frontal cortex, increases circulating CD4-positive lymphocytes. 32 Second, because the enriched environment consists of a running-wheel to enable voluntary physical activity, it is possible that the beneficial effect of environmental enrichment on immunotherapy is also a consequence of physical activity. Physical activity is capable of inducing immune changes via neuroendocrinologic factors such as catecholamines, growth hormone, cortisol, b endorphin, and sex steroids. 33 It has been demonstrated that physical activity enhances natural immunity in both humans and animals, probably through interactions between the central nervous and endocrine systems. 34, 35 Moreover, physical activity improves antibody response after vaccination in mice and human. For instance, in mice, voluntary physical activity in running wheel was found to increase antigen-specific antibody producing B-cell response to tetanus toxoid vaccination. Endogenous opioids may play a role in the enhancement of the secondary antibody response observed after moderate exercise. [36] [37] [38] Furthermore, results of epidemiologic and experimental animal models have shown evidence that increased physical activity is associated with decreased incidence and mortality rates of various cancers. 39 Third, a large number of studies in animals, employing various tumor models, have demonstrated that stress can promote metastasis. Many of these studies have further shown that stress also suppresses various immune indices, suggesting a possible mediating role for cell-mediated immunity. 40 In addition, in humans, higher scores on a measure of dispositional positive affect (pleasurable engagement with the environment) were associated with a greater antibody response to hepatitis B vaccination. 41 Though it is hard to compare positive affects in human and mice, behavioral changes after stimulation by enriched environment have been reported in animals. 27 For example, C3H mice maintained under enriched conditions showed decreased anxiety and better coping skills after exposure to stress. 6 Owing to the complex mechanisms of psychoneuroimmunology interactions it is difficult to identify the factors responsible for the psychologic effect on immunotherapy.
Nevertheless, one has to remember that there are nonimmune mechanisms, which may be responsible for the effect of enrichment on tumor. These include energy balance, oxidative stress, sex hormones, growth factors, and direct influence on tumor growth. All the above are known to be modulated by physical activity. 42 A single factor within the enriched environment that may account for the enhanced antitumor activity cannot be easily isolated. Is it the cognitive effect? Social interactions? Physical activity? Better coping skills? Better welfare? Or any combination of the above? Results of controlled studies could not indicate a single variable that can account for the behavioral and neurobiologic consequences of environmental enrichment.
1,2 Thus further analyses are required to reveal which component of environmental enrichment plays the predominant role in potentiation of cancer immunotherapy.
In conclusion, we found that overall enriched housing conditions compared with standard conditions augmented the efficacy of Id vaccination in murine B-cell lymphoma. Enriched-rearing mice had higher levels of antibodies, smaller tumors, and a better survival rate. These findings have important implications for cancer immunotherapy. Our results are unexpected and intriguing because they show such a great therapeutic effect of a better environment, considering the fact that it is very difficult to find new pharmacologic treatments for cancer, especially in the field of immunotherapy. However, they are certainly preliminary and merit much more in depth study of mechanistic explanations as to the specific pathways through which the effects that we have observed have been accomplished.
